 |
市場調査レポート
禁煙・脱ニコチン中毒製品の世界市場 2015-2023年 (ニコチンガム、パッチ、トローチ剤、吸入薬、スプレー、舌下錠、ほか) ：産業分析、規模、シェア、成長率、動向および予測Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 |
||||||
| 発行 | Transparency Market Research | 商品コード | 298295 | ||||
| 出版日 | ページ情報 | 英文 82 Pages 納期: 即日から翌営業日 |
|||||
| 価格 |
|
||||||
| 禁煙・脱ニコチン中毒製品の世界市場 2015-2023年 (ニコチンガム、パッチ、トローチ剤、吸入薬、スプレー、舌下錠、ほか) ：産業分析、規模、シェア、成長率、動向および予測 Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 | ||
| 出版日: 2016年01月12日 | ページ情報: 英文 82 Pages |
|
禁煙または脱ニコチン中毒は、ニコチン代用製品、電子たばこ (eシガレット) 、Zyban (ブプロピオン) やChantix/Champix (バレニクリン) などの抗うつ薬やニコチン受容体作動薬など、多様な形態によって達成することが可能です。また、禁煙は門医の助けを借りなくても達成可能です。
当レポートでは、世界の禁煙・脱ニコチン中毒製品市場について調査し、市場概要、タイプ・地域別の市場分析と予測、競合情勢の分析、および主要企業のプロファイルなどをまとめ、提供しています。
Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban (bupropion), and Chantix/Champix (varenicline). Quitting smoking is also possible with or without assistance of healthcare professionals. The smoking cessation products market has been extensively analyzed on the basis of factors such as the products popularly used, success rate, and geographical reach.
The global smoking cessation and nicotine de-addiction market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global smoking cessation and nicotine de-addiction market with respect to the segments based on the type of products, and their geographic analysis (by country). A detailed qualitative analysis of driving and restraining factors for the market growth and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global smoking cessation and nicotine de-addiction market.
Based on type of products, the smoking cessation and nicotine de-addiction market includes nicotine replacement therapy (NRT) products, drug therapy and e-cigarettes. The NRT products market is broadly segmented into nicotine containing gums, transdermal patches, lozenges, sublingual tablets, sprays and nasal inhalers. The prominently used brands for smoking cessation are Zyban and Chantix/Champix which comprise the drug therapy segment of the market. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW) The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of USD million for each segment has been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.
A competitive landscape, mapping all the market players and their respective shares in the smoking cessation and nicotine de-addiction products market for 2012 are provided in this report. Some of the major players profiled for NRT products include Johnson & Johnson, GSK, Pfizer, Takeda Pharmaceuticals Co. Ltd., Cipla, and Revolymer PLC. GSK and Pfizer lead the market for drug therapy while the key players profiled for e-cigarettes market include VMR products, and NJOY. Each of these smoking cessation and nicotine de-addiction products market players are profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.
The global smoking cessation and nicotine de-addiction products market has been segmented as follows:
